← FDA DRUG APPROVALS

FDA ANDA · ANDA060572

MYCOLOG-II

Sponsor: MYLAN

APPLICATION
ANDA060572
TYPE
ANDA
ORIGINAL APPROVAL
1985-06-28
LATEST ACTION
1995-11-30
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

MYCOLOG-IIDiscontinued
NYSTATIN 100,000 UNITS/GM, TRIAMCINOLONE ACETONIDE 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · OINTMENT · TOPICAL

Approval history

1995-11-30Manufacturing (CMC) · Supplement 18AP
1992-11-03Labeling · Supplement 17AP
1992-03-23Manufacturing (CMC) · Supplement 15AP
1985-06-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →